1. Home
  2. NEON vs EVAX Comparison

NEON vs EVAX Comparison

Compare NEON & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$0.87

Market Cap

27.5M

Sector

Technology

ML Signal

HOLD

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$3.17

Market Cap

25.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
EVAX
Founded
1997
2008
Country
Sweden
Denmark
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
25.8M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
NEON
EVAX
Price
$0.87
$3.17
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$11.67
AVG Volume (30 Days)
296.5K
24.3K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$2.45
52 Week High
$29.90
$12.15

Technical Indicators

Market Signals
Indicator
NEON
EVAX
Relative Strength Index (RSI) 36.98 40.93
Support Level $0.72 $2.97
Resistance Level $1.05 $3.62
Average True Range (ATR) 0.12 0.25
MACD 0.01 0.02
Stochastic Oscillator 38.06 24.88

Price Performance

Historical Comparison
NEON
EVAX

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: